Veracyte Inc (VCYT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Veracyte Inc (VCYT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7437
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products include Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also provides percepta bronchial genomic classifier an assay to evaluate patients with lung nodules that are suspected for cancer. Veracyte provides genomic testing to other areas of substantial clinical need with diagnostic ambiguity. The company markets its afirma solutions through its sales force across in the US. It also commercializes its products in Brazil. Veracyte is headquartered in South San Francisco, California, the US.

Veracyte Inc (VCYT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Veracyte Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Veracyte Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Veracyte Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Veracyte Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Veracyte Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Veracyte Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Veracyte Raises US$28 Million In Series C Financing 10
Veracyte Secures USD14.95 Million in Venture Funding 12
Allegro Diagnostics Plans To Raise Up To US$20 Million In Series B Financing 13
Partnerships 14
Veracyte Enters into Research Agreement with Loxo Oncology 14
Veracyte Enters into Research Agreement with GE Healthcare 15
Equity Offering 16
Veracyte Raises USD58.9 in Public Offering of Shares 16
Veracyte Raises USD34.3 Million in Public Offering of Shares 18
Veracyte Raises USD40 Million in Private Placement of Shares 20
Veracyte Completes IPO For US$65 Million 22
Acquisition 23
Veracyte Acquires Allegro Diagnostics for USD21 Million 23
Veracyte Inc – Key Competitors 24
Veracyte Inc – Key Employees 25
Veracyte Inc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Financial Announcements 27
Jul 23, 2018: Veracyte reports second quarter 2018 financial results 27
May 01, 2018: Veracyte Reports First Quarter 2018 Financial Results 28
Feb 27, 2018: Veracyte Announces Fourth Quarter and Full-Year 2017 Financial Results 29
Jul 31, 2017: Veracyte Announces Second Quarter 2017 Financial Results 31
May 03, 2017: Veracyte Announces First Quarter 2017 Financial Results 32
Mar 01, 2017: Veracyte Announces Fourth Quarter and Full-Year 2016 Financial Results, Provides 2017 Financial Outlook 33
Corporate Communications 34
Aug 29, 2018: Veracyte appoints Angeline McCabe as vice president, investor relations and corporate communications 34
Feb 28, 2017: Veracyte Announces Executive Promotions 35
Product News 36
Jul 02, 2018: Veracyte Chairman and CEO to Speak at MedCity CONVERGE 36
Jan 19, 2018: Veracyte’s Chief Science and Medical Officer to Present at The Precision Medicine World Conference 37
Other Significant Developments 38
Jan 08, 2018: Veracyte Announces Strategic Realignment And New Appointments To Advance Commercial Growth 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Veracyte Inc, Medical Equipment, Key Facts, 2017 2
Veracyte Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Veracyte Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Veracyte Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Veracyte Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Veracyte Inc, Deals By Market, 2012 to YTD 2018 8
Veracyte Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Veracyte Raises US$28 Million In Series C Financing 10
Veracyte Secures USD14.95 Million in Venture Funding 12
Allegro Diagnostics Plans To Raise Up To US$20 Million In Series B Financing 13
Veracyte Enters into Research Agreement with Loxo Oncology 14
Veracyte Enters into Research Agreement with GE Healthcare 15
Veracyte Raises USD58.9 in Public Offering of Shares 16
Veracyte Raises USD34.3 Million in Public Offering of Shares 18
Veracyte Raises USD40 Million in Private Placement of Shares 20
Veracyte Completes IPO For US$65 Million 22
Veracyte Acquires Allegro Diagnostics for USD21 Million 23
Veracyte Inc, Key Competitors 24
Veracyte Inc, Key Employees 25
Veracyte Inc, Other Locations 26
Veracyte Inc, Subsidiaries 26

List of Figures
Veracyte Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Veracyte Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Veracyte Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Veracyte Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Veracyte Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Veracyte Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Veracyte Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Veracyte Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Veracyte Inc (VCYT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ALLETE Inc (ALE):企業の財務・戦略的SWOT分析
    ALLETE Inc (ALE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • iNova Pharmaceuticals (Australia) Pty Ltd:企業の戦略的SWOT分析
    iNova Pharmaceuticals (Australia) Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Engineers India Ltd (ENGINERSIN):企業の財務・戦略的SWOT分析
    Engineers India Ltd (ENGINERSIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Lonza Group Ltd (LONN):企業の財務・戦略的SWOT分析
    Lonza Group Ltd (LONN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Canpotex Ltd:企業の戦略的SWOT分析
    Canpotex Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Environics Oy:企業の戦略・SWOT・財務情報
    Environics Oy - Strategy, SWOT and Corporate Finance Report Summary Environics Oy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Probi AB (PROB):製薬・医療:M&Aディール及び事業提携情報
    Summary Probi AB (Probi) is a biotechnology company develops, produces and markets probiotics. The company offers licenses for its technology and sells finished products in bulk. It focuses on products for the improvement of gastrointestinal health and immune system. It distributes its products to l …
  • ERM Power Ltd (EPW):企業の財務・戦略的SWOT分析
    ERM Power Ltd (EPW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • NewOcean Energy Holdings Ltd (342):企業の財務・戦略的SWOT分析
    NewOcean Energy Holdings Ltd (342) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • PT Bank Bukopin Tbk:企業の戦略・SWOT・財務分析
    PT Bank Bukopin Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bank Bukopin Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Osaka University-製薬・医療分野:企業M&A・提携分析
    Summary Osaka University (OU) is an educational university that offers undergraduate and graduate courses. The university offers courses in dentistry, economics, engineering, engineering science, foreign studies, human sciences, law and politics, medicine, information science and technology, languag …
  • Flex Ltd (FLEX)-エネルギー分野:企業M&A・提携分析
    Summary Flex Ltd (Flex) formerly Flextronics International Ltd is a provider of technology solutions. It designs, manufactures and provides supply chain services to original equipment manufacturers. The company’s major solutions include disposables, drug delivery, diagnostics devices, automotive ele …
  • PowerFilm, Inc.:企業の戦略的SWOT分析
    PowerFilm, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Baxter International Inc (BAX):医療機器:M&Aディール及び事業提携情報
    Summary Baxter International Inc (Baxter) is a provider of healthcare products, including dialysis in acute and chronic conditions, sterile intravenous solutions, parenteral nutrition therapies, generic injectable pharmaceuticals, infusion systems and devices, inhaled anesthetics, and surgical hemos …
  • Kura Oncology Inc (KURA):企業の財務・戦略的SWOT分析
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics for the treatment of solid tumors and blood cancers. The company’s lead drug candidate Tipifarnib, an inhibitor of farnesyl transferase, an oral investigational drug candi …
  • Dunkin’ Brands Group Inc:企業の戦略・SWOT・財務情報
    Dunkin' Brands Group Inc - Strategy, SWOT and Corporate Finance Report Summary Dunkin' Brands Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Curevac AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Curevac AG (Curevac), formerly CureVac GmbH is a clinical-stage biopharmaceutical company that develops RNA-based medicines. The company develops, designs, and produces messenger RNA molecules for therapeutic and prophylactic vaccines in the fields of oncology and infectious diseases. Its RN …
  • Chiome Bioscience Inc (4583)-製薬・医療分野:企業M&A・提携分析
    Summary Chiome Bioscience Inc (Chiome Bioscience) is a healthcare service company that offers research and development of therapies. The company research and develops antibody drugs for the treatment of autoimmune and inflammatory diseases. Its ADLib system is a monoclonal antibody generating system …
  • ARM Holdings plc:企業の戦略・SWOT・財務情報
    ARM Holdings plc - Strategy, SWOT and Corporate Finance Report Summary ARM Holdings plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Brainsway Ltd (BRIN):企業の財務・戦略的SWOT分析
    Summary Brainsway Ltd (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychopathological disorders. The company provides deep transcranial magnetic stimulation products. It of …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆